Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 2580-2585

  Pericle, Federica ^a   Kirken, Robert A ^b   Bronte, Vincenzo ^a   Sconocchia, Giuseppe ^a   Dasilva, Luis ^b   Segal, David M ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MILK PROTEIN; STAT5 PROTEIN; STAT5A PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; IMMUNE DEFICIENCY; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED BALB C; MILK PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS;

EID: 0031571780     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ochoa, A. C., and D. L. Longo. 1995. Alteration of signal transduction in T cells from cancer patients. In Important Advances in Oncology 1995. V. T. DeVita, S. Hellman, and S. A. Rosenberg, eds. J. B. Lippineott Co., Philadelphia, p. 43.
2. Schreiber, H. 1993. Tumor immunology. In Fundamental Immunology, 3rd ed. W. E. Paul, ed. Raven Press, New York, p. 1143.
3. + T cells. J. Immunol. 149:949.
4. Maeda, H., and A. Shiraishi. 1996. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156:73.
5. Gordon, A. W., and D. M. Lopez. 1995. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses. J. Immunol. 155:3124.
6. Mizoguchi, H., J. J. O'Shea, D. L. Longo, C. M. Loeffler, D. W. McVicar, and A. C. Ochoa. 1992. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795.
7. Salvadori, S., B. Gansbacher, A. M. Pizzimenti, and K. Zier. 1994. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors. J. Immunol. 153:5176.
8. fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity. J. Exp. Med. 182:1029.
9. Yamamoto, N., J. P. Zou, X. F. Li, H. Takenaka, S. Noda, T. Fujii, S. Ono, Y. Kobayashi, N. Mukaida, K. Matsushima, H. Fujhvara, and T. Hamaoka. 1995. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. J. Immunol. 154:2281.
10. Ihle, J. N. 1995. Cytokine receptor signalling. Nature 377:591.
11. Heim, M. H. 1996. The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus. Eur. J. Clin. Invest. 26:1.
12. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
13. Liu, X., G. W. Robinson, F. Gouilleux, B. Groner, and L. Hennighausen. 1995. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA 92:8831.
14. Bronte, V., K. Tsung, J. B. Rao, P. W. Chen, M. Wang, S. A. Rosenberg, and N. P. Restifo. 1995. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J. Immunol. 154:5282.
15. Nanni, P., C. de Giovanni, P. L. Lollini, G. Nicoletti, and G. Prodi. 1983. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis 1:373.
16. Wunderlich, J. R., and G. M. Shearer. 1991. Induction and measurement of cytotoxic T lymphocyte activity, unit 3.11. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 3.11.1.
17. Mond, J. J., and M. Brunswick. 1995. Assays for B cell function In vitro antibody production. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 3.8.1.
18. Leo, O., D. H. Sachs, L. E. Samelson, M. Foo, R. Quinones, R. Gress, and J. A. Bluestone. 1986. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J. Immunol. 137:3874.
19. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53:5613.
20. Franco, J. L., P. Ghosh, R. H. Wiltrout, C. R. Carter, A. H. Zea, N. Momozaki, A. C. Ochoa, D. L. Longo, T. J. Sayers, and K. L. Komschlies. 1995. Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res. 15:3840.
21. Aoe, T., Y. Okamoto, and T. Saito. 1995. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 181:1881.
22. Ghosh, P., A. Sica, H. A. Young, J. Ye, J. L. Franco, R. H. Wiltrout, D. L. Longo, N. R. Rice, and K. L. Komschlies. 1994. Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res. 54:2969.
23. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Sta1 gene results in compromised innate immunity to viral disease. Cell 84:443.
24. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenland, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. I996. Targeted disruption of the Stall gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
25. Thierfelder, W. E., J. M. Van Deuren, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Gronsveld, and J. N. Ihle. 1996. Requirement for Stat4 in interIeukin-12-mediated responses of natural killer and T cells. Nature 382:171.
26. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.
27. Shimoda, K., J. van Deursent, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Gronsveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stato gene. Nature 380:630.
28. Kaplan, M. H., Y. L. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.